219 related articles for article (PubMed ID: 37222047)
41. Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects.
Tian H; Shi G; Yang G; Zhang J; Li Y; Du T; Wang J; Xu F; Cheng L; Zhang X; Dai L; Chen X; Zhang S; Yang Y; Yu D; Wei Y; Deng H
BMC Cancer; 2014 Jan; 14():48. PubMed ID: 24475975
[TBL] [Abstract][Full Text] [Related]
42. Sustained Release of Granulocyte-Macrophage Colony-Stimulating Factor From a Modular Peptide-Based Cancer Vaccine Alters Vaccine Microenvironment and Enhances the Antigen-Specific T-Cell Response.
Nguyen CL; Bui JT; Demcheva M; Vournakis JN; Cole DJ; Gillanders WE
J Immunother (1991); 2001; 24(5):420-429. PubMed ID: 11685084
[TBL] [Abstract][Full Text] [Related]
43. Granulocyte-macrophage colony-stimulating factor induces the differentiation of murine erythroleukaemia cells into dendritic cells.
Cao X; Zhao Y; Yu Y; Wang Y; Zhang M; Zhang W; Wang J
Immunology; 1998 Sep; 95(1):141-7. PubMed ID: 9767469
[TBL] [Abstract][Full Text] [Related]
44. Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines.
Klein C; Bueler H; Mulligan RC
J Exp Med; 2000 May; 191(10):1699-708. PubMed ID: 10811863
[TBL] [Abstract][Full Text] [Related]
45. High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.
Serafini P; Carbley R; Noonan KA; Tan G; Bronte V; Borrello I
Cancer Res; 2004 Sep; 64(17):6337-43. PubMed ID: 15342423
[TBL] [Abstract][Full Text] [Related]
46. Exosome-based cancer vaccine for prevention of lung cancer.
Meng S; Whitt AG; Stamp BF; Eaton JW; Li C; Yaddanapudi K
Stem Cell Investig; 2023; 10():2. PubMed ID: 36742283
[TBL] [Abstract][Full Text] [Related]
47. Delivery of granulocyte-macrophage colony-stimulating factor in bioadhesive hydrogel stimulates migration of dendritic cells in models of human papillomavirus-associated (pre)neoplastic epithelial lesions.
Hubert P; Evrard B; Maillard C; Franzen-Detrooz E; Delattre L; Foidart JM; Noël A; Boniver J; Delvenne P
Antimicrob Agents Chemother; 2004 Nov; 48(11):4342-8. PubMed ID: 15504863
[TBL] [Abstract][Full Text] [Related]
48. Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects.
Bowne WB; Wolchok JD; Hawkins WG; Srinivasan R; Gregor P; Blachere NE; Moroi Y; Engelhorn ME; Houghton AN; Lewis JJ
Cytokines Cell Mol Ther; 1999 Dec; 5(4):217-25. PubMed ID: 10850386
[TBL] [Abstract][Full Text] [Related]
49. Absorbable microparticulate cation exchanger for immunotherapeutic delivery.
Shalaby WS; Yeh H; Woo E; Corbett JT; Gray H; June CH; Shalaby SW
J Biomed Mater Res B Appl Biomater; 2004 May; 69(2):173-82. PubMed ID: 15116407
[TBL] [Abstract][Full Text] [Related]
50. Urban particulate matter suppresses priming of T helper type 1 cells by granulocyte/macrophage colony-stimulating factor-activated human dendritic cells.
Matthews NC; Faith A; Pfeffer P; Lu H; Kelly FJ; Hawrylowicz CM; Lee TH
Am J Respir Cell Mol Biol; 2014 Feb; 50(2):281-91. PubMed ID: 24010813
[TBL] [Abstract][Full Text] [Related]
51. Injectable, Pore-Forming Hydrogels for In Vivo Enrichment of Immature Dendritic Cells.
Verbeke CS; Mooney DJ
Adv Healthc Mater; 2015 Dec; 4(17):2677-87. PubMed ID: 26474318
[TBL] [Abstract][Full Text] [Related]
52. Sequential administration of GM-CSF and IL-2 surface-modified MB49 cells vaccines against the metastatic bladder cancer.
Shi X; Zhang X; Li J; Guo F; Hu Z; Jing Y; Bai L; Chen S; Wan P; Wang F; Gao J; Tan W
Urol Oncol; 2013 Aug; 31(6):883-93. PubMed ID: 21924648
[TBL] [Abstract][Full Text] [Related]
53. Granulocyte macrophage-colony stimulating factor: A key modulator of renal mononuclear phagocyte plasticity.
Mylonas KJ; Anderson J; Sheldrake TA; Hesketh EE; Richards JA; Ferenbach DA; Kluth DC; Savill J; Hughes J
Immunobiology; 2019 Jan; 224(1):60-74. PubMed ID: 30415915
[TBL] [Abstract][Full Text] [Related]
54. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity.
Nakamura M; Iwahashi M; Nakamori M; Ueda K; Matsuura I; Noguchi K; Yamaue H
Clin Cancer Res; 2002 Aug; 8(8):2742-9. PubMed ID: 12171908
[TBL] [Abstract][Full Text] [Related]
55. Big tumor regression induced by GM-CSF gene-modified 3LL tumor cells via facilitating DC maturation and deviation toward CD11c+CD8alpha+ subset.
Lin Y; Xiong S; Zhang L; Zhang Y; Cai Y; Xu L; Chu Y
DNA Cell Biol; 2007 Dec; 26(12):863-72. PubMed ID: 17760559
[TBL] [Abstract][Full Text] [Related]
56. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
[TBL] [Abstract][Full Text] [Related]
57. Modularly engineered injectable hybrid hydrogels based on protein-polymer network as potent immunologic adjuvant in vivo.
Giang Phan VH; Duong HTT; Thambi T; Nguyen TL; Turabee MH; Yin Y; Kim SH; Kim J; Jeong JH; Lee DS
Biomaterials; 2019 Mar; 195():100-110. PubMed ID: 30623788
[TBL] [Abstract][Full Text] [Related]
58. [Application of fusion gene mGM-CSF/hIL-2 to specific immunotherapy induced by hepatic tumor cell vaccine].
Yang W; Guo C; Liu QG
Ai Zheng; 2008 Feb; 27(2):149-54. PubMed ID: 18279611
[TBL] [Abstract][Full Text] [Related]
59. Interferon-gamma or granulocyte-macrophage colony-stimulating factor administered as adjuvants with a vaccine of irradiated autologous tumor cells from short-term cell line cultures: a randomized phase 2 trial of the cancer biotherapy research group.
Dillman RO; Wiemann M; Nayak SK; DeLeon C; Hood K; DePriest C
J Immunother; 2003; 26(4):367-73. PubMed ID: 12843799
[TBL] [Abstract][Full Text] [Related]
60. Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacity.
Curiel-Lewandrowski C; Mahnke K; Labeur M; Roters B; Schmidt W; Granstein RD; Luger TA; Schwarz T; Grabbe S
J Immunol; 1999 Jul; 163(1):174-83. PubMed ID: 10384114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
